NCT00349635已完成2 期
A Double-Blind, 3-Arm Study on Weight Loss With a Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Per Day Compared to Metformin 1,700 mg and to Placebo, at 6 Months, in Obese Patients, Followed by: A Double-Blind, 2-Arm Investigation of Weight-Loss Maintenance With the Same Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Compared to Placebo, at 6 Months, in the Responders.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 148
- 试验地点
- 3
- 主要终点
- Weight
研究概览
简要总结
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 30 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Both genders, BMI ≥ 30 kg/m² and <40 kg/m².
排除标准
- •Known abnormal thyroid hormone levels, or high thyroid stimulating hormone (TSH) level.
结局指标
主要结局
Weight
次要结局
- Waist and hip circumference
研究者
研究点 (3)
Loading locations...
相似试验
已完成
3 期
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 DiabetesType 2 Diabetes MellitusNCT00855166AstraZeneca182
已完成
3 期
Metformin in Obese Children and AdolescentsObesityInsulin ResistanceNCT01487993St. Antonius Hospital62
已完成
2 期
A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.Patients With Metabolic SyndromeNCT00703755Solvay Pharmaceuticals2,288
Unknown
2 期
Glaser Obesity StudyObesityNCT00209482Glaser Pediatric Research Network76
已完成
2 期
Combination of Metformin With Gefitinib to Treat NSCLCEGFR Gene AmplificationAdvanced CancerStage IIIB NSCLCStage IV NSCLCNSCLCNCT01864681Daping Hospital and the Research Institute of Surgery of the Third Military Medical University224